Old Web
English
Sign In
Acemap
>
authorDetail
>
Omotayo Arowojolu
Omotayo Arowojolu
Johns Hopkins University
Protein kinase B
Targeted therapy
Myeloid leukemia
Fms-Like Tyrosine Kinase 3
Kinase
3
Papers
212
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A potential therapeutic target for FLT3-ITD AML: PIM1 Kinase
2012
Leukemia Research
Amir T. Fathi
Omotayo Arowojolu
Ian Swinnen
Takashi Sato
Trivikram Rajkhowa
Donald Small
Fredrik P. Marmsater
John E. Robinson
Stefan D. Gross
Matthew Martinson
Shelley Allen
Nicholas C. Kallan
Mark J. Levis
Show All
Source
Cite
Save
Citations (48)
The Novel Inhibitor PLX3397 Effectively Inhibits FLT3-Mutant AML,
2011
Blood
Elizabeth A. Burton
Bernice Wong
Jiazhong Zhang
Brian L. West
Gideon Bollag
Gaston Habets
Allison Galanis
Hoa Nguyen
Omotayo Arowojolu
Trivikram Rajhowa
Mark J. Levis
Show All
Source
Cite
Save
Citations (14)
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
2009
Blood
Keith W. Pratz
Jorge E. Cortes
Gail J. Roboz
Niranjan Rao
Omotayo Arowojolu
Adam Stine
Yukimasa Shiotsu
Aiko Shudo
Shiro Akinaga
Donald Small
Judith E. Karp
Mark J. Levis
Show All
Source
Cite
Save
Citations (150)
1